IXSBF (InNexus Biotechnology) Debt-to-Asset : 2.13 (As of Mar. 2011)

InNexus Biotechnology Debt-to-Asset Chart

InNexus Biotechnology Annual Data
	Trend	Jun01	Jun02	Jun03	Jun04	Jun05	Jun06	Jun07	Jun08	Jun09	Jun10
Debt-to-Asset		Get a 7-Day Free Trial					-	-	-	0.55	0.98

InNexus Biotechnology Quarterly Data
	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11
Debt-to-Asset	Get a 7-Day Free Trial															1.32	0.98	1.90	1.97	2.13

Competitive Comparison of InNexus Biotechnology's Debt-to-Asset

For the Biotechnology subindustry, InNexus Biotechnology's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

InNexus Biotechnology's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, InNexus Biotechnology's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where InNexus Biotechnology's Debt-to-Asset falls into.

InNexus Biotechnology Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

InNexus Biotechnology's Debt-to-Asset for the fiscal year that ended in Jun. 2010 is calculated as

InNexus Biotechnology's Debt-to-Asset for the quarter that ended in Mar. 2011 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InNexus Biotechnology  (GREY:IXSBF) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

InNexus Biotechnology Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of InNexus Biotechnology's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

InNexus Biotechnology Business Description